Presentation RDF
pages:- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- more...
- Hypertension Pharmacogenomics: An Update Invited Talk
- Hypertension pharmacogenomics: Discoveries and opportunities Invited Talk
- Hypertension Pharmacogenomics: Discoveries and potential to guide hypertension therapy with genetics Invited Talk
- Hypertension pharmacogenomics: Update on PEAR and INVEST Invited Talk
- Hypertension pharmacogenomics: Using ‘omics technologies to advance discovery Invited Talk
- Hypnosis for pain management: Feasibility of music as a hypnotic induction
- I (can’t) Walk the Line: Differentiating between septic arthritis and transient synovitis in the acutely limping child
- I Told You So!
- iAMP21 Is Associated with Inferior Outcomes in Children with Acute Lymphoblastic Leukemia (ALL) on Contemporary Children's Oncology Group (COG) Studies
- iAMP21 Is Associated with Inferior Outcomes in Children with Acute Lymphoblastic Leukemia (ALL) on Contemporary Children’s Oncology Group (COG) Studies
- iAttending: Becoming a More Efficient and Effective Medical Educator
- IBD and Pregnancy Invited Talk
- IBD in Autoimmunity
- IBD Update 2013
- IBM vs Macintosh?
- ICP and PbtO2 monitoring
- ICV infusion of IL-1beta and its effect on glial fibrillary acidic protein, ïbeta-amyloid precursor protein and Abeta in transgenic mice
- Identification of a safe and biologically active dose of the FLT3 inhibitor lestaurtinib in combination with chemotherapy in infants with MLL-rearranged (MLL-4) ALL: A Children's Oncology Group Study, 2011
- Identification of CRLF2 Genomic lesions in patients with pediatric B-precursor Acute Lymphoblastic Leukemia (BCP ALL) by Flow Cytometry or Quantitative RT-PCR: A Children's Oncology Group (COG) Study
- Identification of Effective Antivirals Against SARS-CoV-2 via Translational Antiviral Pharmacology Invited Talk
- Identification of Novel Cluster Groups in High-Risk Pediatric B-Precursor Acute Lymphoblastic Leukemia (HR-ALL) by Gene Expression Profiling: Correlation with Clinical and Outcome Variables. a Children's Oncology Group (COG) Study
- Identification of Novel Virulence Genes Associated with Severe Infections (SI) in Clinical Isolates of Staphylococcus aureus Using Comparative Genome Hybridization (CGH)
- Identification of peptidic sequences as potential modulators of microglial activation as a therapeutic approach to Alzheimer's Disease
- Identification of Potential Virulence-Associated Genes in a Clinical Population of Methicillin-Resistant Staphylococcus aureus (MRSA) Using Comparative Genome Hybridization (CGH)
- Identification of Potential Virulence-Associated Genes in a Clinical Population of Staphylococcus aureus Using Suppression Subtractive Hybridization (SSH)
- Identifying and Addressing Mental Health Disparities in the Gator Nation Using Electronic Records Invited Talk
- Identifying and Treating Delirium in the Hospital Setting Invited Talk
- Identifying Categories of Over-the-counter Products with Superior Outbreak Detection Performance Invited Talk
- Identifying Children with Special Health Care Needs
- Identifying Collaborative Relationships and Interconnections Between Research Communities Using LinkedIn Maps Invited Talk